Trial Details
COMPLETEDBasic Information
| Clinical ID | c1866 |
|---|---|
| Identifier | NCT04312659 |
| Trial Title | A Study of Infliximab in the Treatment of Chinese Children With Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Infliximab |
Participant Information
| Sponsor | Johnson & Johnson (China) Investment Ltd. |
|---|---|
| City | Guangzhou |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2020-07-15 |
|---|---|
| Primary Completion Date | 2023-09-12 |
| Completion Date | 2023-09-12 |